Form 4 filed by Marks Gilbert Lynn
Marks Gilbert Lynn filed this Form 4 on ANTX (AN2 Therapeutics, Inc.) with 1 transaction row and 0 holding rows, accepted by EDGAR 2026-10-13 21:13:17 UTC.
- Accession
- 0001193125-26-420643
- Filer
- CIK 1916940
- Filed
- 2026-10-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ANTX · AN2 Therapeutics, Inc. (CIK 1880438)
- Marks Gilbert Lynn director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-12 | A granted | +2,283 | $0 | 84,156 | D |